| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 22529-29-9 | Molybdenum fluorideoxide (MoF3O), (T-4)- (9CI); Molybdenumfluoride oxide (MoF3O); Molybdenum fluoride oxide (MoOF3) (8CI); Molybdenumtrifluoride monoxide |  | F3MoO-3 | 詳情 | 供應(yīng)商 | |
| 13181-62-9 | Methanimidamide,N'-(3-chloro-2-methylphenyl)-N,N-dimethyl-; Formamidine,N'-(3-chloro-o-tolyl)-N,N-dimethyl- (7CI,8CI) |  | C10H13ClN2 | 詳情 | 供應(yīng)商 | |
| 64965-63-5 | Morpholine,4-[(cyanoimino)methyl]-3-methyl-2-phenyl- (9CI); NSC 274901 |  | C13H15N3O | 詳情 | 供應(yīng)商 | |
| 64038-95-5 | Methanone,4-morpholinyl(3,4,5-triethoxyphenyl)-; Morpholine,4-(3,4,5-triethoxybenzoyl)- (7CI,9CI) |  | C17H25NO5 | 詳情 | 供應(yīng)商 | |
| 7357-16-6 | Methanone,bis[4-hydroxy-3-(4-morpholinylmethyl)-5-nitrophenyl]-; bis[4-hydroxy-3-(morpholin-4-ylmethyl)-5-nitro-phenyl]methanone |  | C23H26N4O9 | 詳情 | 供應(yīng)商 | |
| 124444-74-2 | Methanone,[4-(2,3-dimethylphenyl)-1-piperazinyl]-3-pyridinyl-, hydrochloride (1:2); Piperazine,1-(2,3-dimethylphenyl)-4-(3-pyridinylcarbonyl)-, dihydrochloride (9CI) |  | C18H23Cl2N3O | 詳情 | 供應(yīng)商 | |
| 64048-06-2 | Mercurate(1-),ethyl[mercaptoacetato(2)-O,S]-, potassium (9CI); Aceticacid, mercapto-, mercury complex |  | C4H7HgO2S.K | 詳情 | 供應(yīng)商 | |
| 23209-59-8 | Metaphosphoric acid(HPO3), calcium sodium salt (1:?:?); Metaphosphoricacid (HPO3), calcium sodium salt (8CI,9CI) |  | Ca.xHO3P.xNa | 詳情 | 供應(yīng)商 | |
| 28882-09-9 | Methyl, bromodifluoro-(8CI,9CI); Bromodifluoromethyl; Bromodifluoromethyl radical |  | CBrF2* | 詳情 | 供應(yīng)商 | |
| 63701-83-7 | Morphinan-4,8-alpha-diol, 3-methoxy-17-methyl- |  | C18H25NO3 | 詳情 | 供應(yīng)商 | |
| 79798-39-3 | Morphinan-6-one,17-(cyclopropylmethyl)-4-hydroxy-; Ketorfanol; SBW 22 |  | C20H25NO2 | 詳情 | 供應(yīng)商 | |
| 31594-06-6 | Monamycin H1 (8CI,9CI); 2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazacyclooctadecine,cyclic peptide deriv.; D-Valine, N-[1-[N-[[2-[[D-trans-5-chlorohexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-,p-lactone; N-[1-[N-[[2-[[D-trans-5-Chlorohexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-D-valinep-lactone |  | C34H56ClN7O8 | 詳情 | 供應(yīng)商 | |
| 2201-40-3 | Morpholine,4-(1-phenylcyclohexyl)-; 1-(1-Phenylcyclohexyl)morpholine; 4-(1-Phenylcyclohexyl)morpholine |  | C16H23NO | 詳情 | 供應(yīng)商 | |
| 34604-38-1 | Mercury,(acetato-O)phenyl-, ammoniate (9CI); Phenylmercuryammonium acetate |  | C8H11HgNO2 | 詳情 | 供應(yīng)商 | |
| 24225-08-9 | Methanesulfonyl cyanide; Methylsulfonylcyanide |  | C2H3NO2S | 詳情 | 供應(yīng)商 | |
| 64049-28-1 | Mercury,bis(acetato-O)bis[m-(2-amino-5-nitro-1,3-phenylene)]tri- (9CI); Benzenamine,4-nitro-, mercury complex |  | C16H14Hg3N4O8 | 詳情 | 供應(yīng)商 | |
| 50901-95-6 | Morpholine,4-(3,4-dihydro-2-methyl-3-phenyl-2H-pyrrol-5-yl)-; Morpholine, 4-(3,4-dihydro-2-methyl-3-phenyl-2H-pyrrol-5-yl)- |  | C15H20N2O | 詳情 | 供應(yīng)商 | |
| 129833-05-2 | Microviridin A (9CI); Microviridin; 26,9-(Butaniminobutaniminomethano)-15,3-(iminomethano)pyrrolo[2,1-f][1,20,4,7,10,13,16,25,28]dioxaheptaazacyclodotriacontine,cyclic peptide deriv.; L-Tyrosine,N-acetyl-L-tyrosylglycylglycyl-L-threonyl-L-phenylalanyl-L-lysyl-L-tyrosyl-L-prolyl-L-seryl-L-a-aspartyl-L-tryptophyl-L-a-glutamyl-L-a-glutamyl-, cyclic (13® 6)-peptide, (10® 4),(12® 9)-dilactone; N-Acetyl-L-tyrosylglycylglycyl-L-threonyl-L-phenylalanyl-L-lysyl-L-tyrosyl-L-prolyl-L-seryl-L-a-aspartyl-L-tryptophyl-L-a-glutamyl-L-a-glutamyl-L-tyrosine cyclic (13® 6)-peptide (10® 4),(12® 9)-dilactone |  | C85H100N16O24 | 詳情 | 供應(yīng)商 | |
| 22644-56-0 | m-Dioxane,5-ethyl-5-(1-methoxyethyl)-2-methyl-, trans- (8CI) |  | C10H20O3 | 詳情 | 供應(yīng)商 | |
| 15932-89-5 | Methanol, hydroperoxy-(9CI); Hydroperoxide,hydroxymethyl (6CI); Hydroxymethyl hydroperoxide |  | CH3O* | 詳情 | 供應(yīng)商 | |